Aquestive Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	537	788	325	135	49	156
Market Cap Growth	34.33%	142.81%	140.67%	176.07%	-68.73%	-13.14%
Enterprise Value	498	700	284	155	85	169
Last Close Price	4.25	6.46	3.56	2.02	0.90	3.89
PS Ratio	9.86	17.69	5.64	2.67	1.02	3.07
PB Ratio	-	-23.41	-5.40	-1.27	-0.41	-1.90
EV/Sales Ratio	9.13	15.73	4.93	3.06	1.79	3.32
Debt / Equity Ratio	-1.04	-1.26	-0.63	-0.31	-0.48	-0.69
Net Debt / Equity Ratio	0.70	2.34	0.56	-0.09	-0.25	-0.35
Net Debt / EBITDA Ratio	0.76	1.12	1.12	-0.69	-0.76	-0.90
Net Debt / FCF Ratio	0.86	1.49	0.93	-1.28	-2.79	-0.84
Asset Turnover	0.48	0.34	0.73	0.88	0.80	0.81
Inventory Turnover	2.30	3.04	2.79	3.32	3.95	4.61
Quick Ratio	6.54	2.92	4.18	1.77	0.81	1.83
Current Ratio	7.19	3.14	4.68	2.24	1.01	2.15
Return on Assets (ROA)	-29.20%	-33.92%	-24.21%	-16.49%	-44.16%	-34.71%
Return on Capital Employed (ROCE)	-45.60%	-63.00%	-37.30%	-38.60%	-239.80%	-86.60%
Earnings Yield	-14.67%	-10.63%	-13.60%	-5.83%	-111.37%	-45.15%
FCF Yield	-8.61%	-6.72%	-11.07%	-5.47%	-22.20%	-21.69%
Buyback Yield / Dilution	-27.37%	-23.29%	-41.58%	-25.69%	-27.99%	-13.15%

SEC Filings: 10-K · 10-Q